Radiological conjugating agents (RCA) are drugs or diagnostic agents that contain a radioactive substance and a conjugating agent.
When administered the conjugating agent and the attached radioactive substance specifically bind and accumulate in the target cells.
When used as a diagnostic agent the radioactive target cells can be detected for imaging purposes. As a cancer treatment, RCA causes cellular damage to the target cells due the emission from radioactive substance.
Name | Updated |
---|---|
Ibritumomab (Ibritumomab [ ib-ri-tyoo-mo-mab ]) | 13-Aug-2023 |
Lymphoseek (Technetium tc 99m tilmanocept) | 13-Jul-2023 |